Home Tags [vic-]trastuzumab duocarmazine

Tag: [vic-]trastuzumab duocarmazine

Highlights in Development: September 2019

In September 2019, a number of articles discussing antibody-drug conjugates were published in a variety of journals.  Here is an overview of some of...

Trastuzumab Duocarmazine Granted U.S. FDA Fast Track Designation for Pre-treated HER2+...

The United States Food & Drug Administration (FDA) has granted Fast Track designation for The Netherlands-based Synthon Biopharmaceuticals investigational anti-HER2 antibody-drug conjugate or ADC...